1st Quarter - Report

IPOLICY SOLUTIONS for GLOBAL HEALTHY LIVING FOUNDATION

Firm
Client
Income
$19,500
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor and Pensions

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 4455 (116th), S. 1895 (116th), H.R. 4400 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.